A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune ...

REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of ...

A research team led by the School of Public Health in the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in ...

In type 1 diabetes, the body’s own immune system turns against the pancreas. Cells meant to protect you start destroying ...

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune ...

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

BOCA RATON, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company”), a clinical-stage ...

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) ("CERo” or the "Company”) an innovative immunotherapy company seeking to ...

BioVaxys Technology and Sona Nanotech have signed a research agreement to develop cancer therapeutics utilising the former’s ...

Researchers identified a natural 'brake' within the innate immune system: the inhibitory receptor Siglec-E (SigE) and its human counterparts, Siglec-7 and Siglec-9. This receptor helps prevent ...

The leading Merkel Cell Carcinoma Companies such as ImmunityBio, OncoSec Medical, Exelixis, 4SC, Kartos Therapeutics, Incyte ...